Dienstag, 15. November 2018
The Bearish Perspective
William White has been a much respected advisor to key central bankers and policy makers since the late '80s! He is famously recognized for his critical views on current monetary policy. On the 15th of November '18, William White was kind enough to join us together with GAM's Emerging Markets bond and currency veteran Paul McNamara to discuss likely risk scenarios and their potential implications.
Dienstag, 20. März 2018
Picking winners, when indices
are fully priced
Thomas Braun, Tim Regan and Michel Degosciu are three experienced value investing practitioners. On March 20th we invited them to discuss how they spot and analyse investment opportunities. We asked them to reveal some of their current top picks as well as their general view on markets.
Dienstag, 3. März 2017
On the couch with Howard Marks
Howard Marks is one of the legends of value investing! As co-founder of Oaktree Capital he built one of the most consistent investment track records in corporate bonds as well as a highly successful and respected private equity business. On 7. March 2017 we had the opportunity to listen to Howard Marks explain his investment philosophy and his current take on financial markets.
Freitag, 3. Juni 2016
A Conversation with
Prof. Robert Shiller
Prof. Robert Shiller is one of the great economic thinkers of our time! The Cancer Charity Support Fund is proud to take inspiration from his thought provoking ideas on capitalism and the common good. On 3. June we had the opportunity to listen to Prof. Robert Shiller in person.
Mittwoch, 6. April 2016
India Rising - Moment of truth?
Amongst many other things, India is an emerging force in pharmaceutical innovation, a topic that is highly relevant to the Cancer Charity Support Fund. On the 6. April we invited three experts to discuss how India is progressing despite many obstacles.
Donnerstag, 12. November 2015
Kampf gegen Krebs - Goldrausch oder Altruismus
Mit einem Investment in den Cancer Charity Support Fund engagiert sich der Anleger im Kampf gegen Krebs! Wo Forschung, Politik, Gesellschaft und die Industrie aktuell stehen haben wir am 12 November mit 3 Experten diskutiert.